Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.01 USD
Change Today +0.34 / 6.00%
Volume 1.1M
PACB On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

pacific biosciences of calif (PACB) Snapshot

Open
$5.97
Previous Close
$5.67
Day High
$6.11
Day Low
$5.70
52 Week High
01/13/15 - $8.78
52 Week Low
05/9/14 - $4.02
Market Cap
448.0M
Average Volume 10 Days
617.5K
EPS TTM
$-0.94
Shares Outstanding
74.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PACIFIC BIOSCIENCES OF CALIF (PACB)

pacific biosciences of calif (PACB) Related Bloomberg News

View More Bloomberg News

pacific biosciences of calif (PACB) Related Businessweek News

View More BusinessWeek News

pacific biosciences of calif (PACB) Details

Pacific Biosciences of California, Inc. designs, develops, manufactures, and markets an integrated platform for genetic analysis. The company provides single molecule real-time (SMRT) technology platform, which enables single molecule real-time detection of biological processes. It offers PacBio RS II high resolution genetic analyzer, an instrument that conducts, monitors, and analyzes single molecule biochemical reactions in real time. The company provides consumable products, which include sealed and packaged SMRT Cells, as well as various reagent kits, such as template preparation kits, binding kits, and sequencing kits to run the PacBio RS II. Its customers include research institutions, commercial laboratories, genome centers, clinical, government and academic institutions, genomics service providers, pharmaceutical companies, and agricultural companies. The company markets its products through a direct sales force in North America and Europe as well as primarily through distributors in Asia. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.

344 Employees
Last Reported Date: 03/12/15
Founded in 2000

pacific biosciences of calif (PACB) Top Compensated Officers

Executive Chairman, Chief Executive Officer a...
Total Annual Compensation: $1.0
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $1.0
Senior Vice President of Market Development
Total Annual Compensation: $399.0K
Senior Vice President of Research and Develop...
Total Annual Compensation: $399.0K
Compensation as of Fiscal Year 2014.

pacific biosciences of calif (PACB) Key Developments

Pacific Biosciences Introduces New Solutions for Comprehensive and Efficient Targeted Sequencing and Multiplexing of Samples

Pacific Biosciences of California, Inc. announced the introduction of several new solutions for targeted sequencing applications. The company has introduced a new workflow that combines Roche NimbleGen's SeqCap EZ enrichment technology with large DNA fragments (up to 6 kb) and PacBio's Single Molecule, Real-Time (SMRT®) Sequencing to provide a more comprehensive view of variants, transgene integration sites, and haplotype information over multi-kilobase contiguous regions. The long fragments capture haplotype information that provide a more inclusive view of the targeted region of interest, allowing a comprehensive look at variants in exons, introns and intergenic regions, as well as generation of accurate haplotypes. PacBio also announced the launch of two multiplexing workflows and associated products for barcoding samples prior to running on SMRT Cells. The new barcoding kits allow customers to pool many samples and thus reduce the cost per sample and the total time for sample preparation. By employing the barcoding strategies, researchers can efficiently focus on even more defined genomic regions. And by barcoding samples, researchers have the flexibility to multiplex samples or targets within a sample or a combination of both.

Pacific Biosciences of California, Inc. Announces Executive Changes

On April 13, 2015, Brian B. Dow tendered his resignation as Vice President and Principal Accounting Officer of Pacific Biosciences of California, Inc., effective April 15, 2015. Mr. Dows departure is not the result of any material disagreement with the Company regarding its operations, policies or practices. Susan K. Barnes, the Companys Executive Vice President and Chief Financial Officer, will serve as the Companys Principal Accounting Officer. Ms. Barnes has served as the Companys Executive Vice President and Chief Financial Officer since 2010. Ms. Barnes has no family relationship with any of the Companys executive officers or directors.

Pacific Biosciences of California, Inc. Announces Executives Appointments

On March 4, 2015, Kathy Ordoñez was appointed to serve on the Compensation Committee and the Science and Technology Committee of the Board of Pacific Biosciences of California, Inc., effective immediately after the company’s 2015 Annual Meeting of stockholders. Directors Lucy Shapiro, Ph.D., and David Botstein, Ph.D. were also appointed to serve on the Science and Technology Committee of the Board, effective immediately after the company’s 2015 Annual Meeting of stockholders, with Dr. Shapiro to serve as committee chair.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PACB:US $6.01 USD +0.34

PACB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Enzo Biochem Inc $2.80 USD +0.02
IntelliCell BioSciences Inc $0.0001 USD 0.00
NanoString Technologies Inc $12.40 USD -0.27
Sequenom Inc $4.65 USD +0.06
WaferGen Bio-systems Inc $4.35 USD +0.02
View Industry Companies
 

Industry Analysis

PACB

Industry Average

Valuation PACB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.8x
Price/Book 7.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PACIFIC BIOSCIENCES OF CALIF, please visit www.pacificbiosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.